Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Magnetoencephalography Reveals Neuroprotection of COVID-19 Vaccination in Nonhuman Primates.

Vaccines·2026
Same author

A single dose of purified human antibody from transchromosomic bovines mitigates aerosolized Venezuelan equine encephalitis virus disease in cynomolgus macaques.

PloS one·2026
Same author

Comparing SARS-CoV-2 infections in the US Military Health System and national data: opportunities for future pandemic surveillance.

Frontiers in public health·2026
Same author

SARS-CoV-2 infection and sleep health in Military Health System beneficiaries.

Sleep advances : a journal of the Sleep Research Society·2026
Same author

Healthcare Workers Have More Frequent and Less Severe Influenza-Like Illness Than Non-healthcare Workers: Findings From the PAIVED Study.

Open forum infectious diseases·2026
Same author

Evaluating the risk and risk factors of dysautonomia as a post-acute sequelae of COVID-19: a secondary analysis of a matched case-control dataset.

Frontiers in neurology·2025

Related Experiment Video

Updated: Jun 22, 2026

A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum
07:06

A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum

Published on: April 10, 2018

Advances in dengue vaccine development.

Kanakatte Raviprakash1, Gabriel Defang, Timothy Burgess

  • 1Naval Medical Research Center, Silver Spring, MD, USA. Kanakatte.raviprakas@med.navy.mil

Human Vaccines
|June 19, 2009
PubMed
Summary

Dengue viruses, a major arbovirus threat, are expanding globally. Vaccine development is accelerating due to disease burden and market potential, with progress and challenges being reviewed.

Area of Science:

  • Arbovirology
  • Vaccinology
  • Epidemiology

Background:

  • Dengue viruses are significant arboviruses responsible for substantial human illness.
  • Recent decades have seen a global expansion of dengue, increasing its public health impact.
  • The considerable disease burden and market opportunities have driven vaccine research.

Purpose of the Study:

  • To review recent advancements in dengue vaccine development.
  • To discuss the obstacles hindering the creation of effective dengue vaccines.

Main Methods:

  • Literature review of recent dengue vaccine research.
  • Analysis of progress and challenges in vaccine development.

Main Results:

  • Significant activity in dengue vaccine development is noted.

More Related Videos

Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction
08:36

Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction

Published on: November 1, 2018

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
04:23

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

Related Experiment Videos

Last Updated: Jun 22, 2026

A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum
07:06

A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum

Published on: April 10, 2018

Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction
08:36

Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction

Published on: November 1, 2018

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
04:23

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

  • Progress has been made, but obstacles remain.

    • Conclusions:

    • Vaccine development for dengue is a dynamic field driven by global expansion and disease impact.
    • Continued research is necessary to overcome existing challenges and achieve successful dengue vaccine implementation.